NASTAD Announces 2018-2019 Board of Directors

FOR IMMEDIATE RELEASE May 31, 2018

CONTACT: Kyle Taylor ktaylor@nastad.org | 202.434.7134

NASTAD Announces 2018-2019 Board of Directors

Washington, DC - Last week, NASTAD, a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. and around the world, announced its 2018-2019 Board of Directors. NASTAD is governed by a 23-member, elected Board charged with making policy and program decisions on behalf of the full membership.   The 2018-2019 Board of Directors includes:  Officers (Executive Committee) Jacquelyn Clymore, North Carolina, Chair Johanne Morne, New York, Chair-Elect Jeffrey Hitt, Maryland, Vice-Chair Michael Kharfen, District of Columbia, Secretary-Treasurer  DeAnn Gruber, Louisiana, Immediate Past-Chair (ex-officio)  Board Members Sharon Jordan, Alabama Susan Jones, Alaska John Sapero, Arizona Karen Mark, California Dave Kern, Chicago William Lyons, Georgia Peter Whiticar, Hawaii Marlene McNeese, Houston Aimee Shipman, Idaho Eduardo Alvarado, Illinois Randy Mayer, Iowa Dawn Fukuda, Massachusetts James Stewart, Mississippi Andrew Gans, New Mexico Demetre Daskalakis, New York City Jan Fox, Oklahoma Tracey Packer, San Francisco Beth Crutsinger-Perry, Washington  Executive Director Murray C. Penner (ex-officio)   “It is my pleasure to welcome the 2018-2019 Board of Directors,” said Murray Penner, NASTAD Executive Director. “I look forward to a productive and eventful year as we work together under the guidance of our Board Chair’s Challenge: Achieving Health Equity to End the Epidemics. By strengthening partnerships, promoting leadership, and eliminating stigma and discrimination, we can end the HIV and hepatitis epidemics.”

About NASTAD

Founded in 1992, NASTAD is a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. and around the world. Our singular mission is to end the intersecting epidemics of HIV, viral hepatitis, and related conditions. We do this work by strengthening domestic and global governmental public health through advocacy, capacity building, and social justice.

###